Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.98 USD | +1.68% | -6.83% | +37.73% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.73% | 270M | |
+24.39% | 46.71B | |
+48.83% | 41.8B | |
-1.08% | 41.52B | |
-3.42% | 29.55B | |
+10.27% | 25.78B | |
-21.33% | 19.26B | |
+0.83% | 12.14B | |
-3.27% | 12.08B | |
+27.05% | 11.98B |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Receives Speculative Risk Qualifier on Sector Perform Rating From RBC, Price Target Cut to $15 From $25